From the Journals
News
Expert Point of View: David G. Huntsman, MD
June 10, 2020
By Alice Goodman
1 min read
Study discussant David G. Huntsman, MD, Founder and Chief Medical Officer of Contextual Genomics, noted the positive predictive value of DETECT-A was 19%, which increased to 41% with the addition of positron-emission tomography/computed tomography. He pointed out that most cancers detected by the blood-based screening test were local or regional. When the test was combined with conventional screening methods, the number of cancers doubled.
Dr. Huntsman cited the following unanswered questions:
- What types of usual screening methods were used?
- How were false-positive results ruled out?
- How would the test’s sensitivity and negative predictive value be determined without the use of whole-body magnetic resonance imaging or some other method?
- How long until a meaningful survival analysis can be performed?
- What is the optimal testing schedule?
- Will such screening contribute to overdiagnosis and overtreatment?
DISCLOSURE: Dr. Huntsman is Founder and Chief Medical Officer of Contextual Genomics.